Hemant S. Murthy

3.1k total citations
105 papers, 742 citations indexed

About

Hemant S. Murthy is a scholar working on Oncology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hemant S. Murthy has authored 105 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 47 papers in Hematology and 18 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hemant S. Murthy's work include CAR-T cell therapy research (31 papers), Hematopoietic Stem Cell Transplantation (19 papers) and Acute Myeloid Leukemia Research (19 papers). Hemant S. Murthy is often cited by papers focused on CAR-T cell therapy research (31 papers), Hematopoietic Stem Cell Transplantation (19 papers) and Acute Myeloid Leukemia Research (19 papers). Hemant S. Murthy collaborates with scholars based in United States, Saudi Arabia and France. Hemant S. Murthy's co-authors include Mohamed A. Kharfan‐Dabaja, Madiha Iqbal, Julio C. Chávez, Ernesto Ayala, John R. Wingard, Ambuj Kumar, Aparna Hegde, Nosha Farhadfar, Tea Reljic and B.T. Naveen Kumar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hemant S. Murthy

87 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hemant S. Murthy United States	15	346	230	146	126	81	105	742
Jordi Sierra Spain	14	375 1.1×	590 2.6×	272 1.9×	193 1.5×	162 2.0×	26	1.0k
Chris Fraser Australia	16	193 0.6×	135 0.6×	144 1.0×	201 1.6×	151 1.9×	42	1.0k
Shih‐Hsiang Chen Taiwan	17	88 0.3×	296 1.3×	133 0.9×	253 2.0×	166 2.0×	106	897
Siraj M. El Jamal United States	16	187 0.5×	115 0.5×	75 0.5×	131 1.0×	39 0.5×	46	670
Satya Prakash Yadav India	12	93 0.3×	155 0.7×	101 0.7×	159 1.3×	75 0.9×	98	627
Yigal Barak Israel	13	98 0.3×	244 1.1×	132 0.9×	127 1.0×	62 0.8×	26	673
A Adler United States	13	269 0.8×	170 0.7×	227 1.6×	158 1.3×	58 0.7×	38	822
Navid Bouzari Iran	14	66 0.2×	209 0.9×	76 0.5×	49 0.4×	67 0.8×	27	868
Serap Aksoylar Türkiye	16	76 0.2×	85 0.4×	110 0.8×	105 0.8×	118 1.5×	47	603
Gustav Fischmeister Austria	13	92 0.3×	159 0.7×	65 0.4×	46 0.4×	40 0.5×	19	416

Countries citing papers authored by Hemant S. Murthy

Since Specialization

Citations

This map shows the geographic impact of Hemant S. Murthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hemant S. Murthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hemant S. Murthy more than expected).

Fields of papers citing papers by Hemant S. Murthy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hemant S. Murthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hemant S. Murthy. The network helps show where Hemant S. Murthy may publish in the future.

Co-authorship network of co-authors of Hemant S. Murthy

This figure shows the co-authorship network connecting the top 25 collaborators of Hemant S. Murthy. A scholar is included among the top collaborators of Hemant S. Murthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hemant S. Murthy. Hemant S. Murthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mercadal, Santiago, Kwang Woo Ahn, Praveen Ramakrishnan Geethakumari, et al.. (2024). Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy. Haematologica. 110(1). 218–221. 3 indexed citations

Badar, Talha, Terra L. Lasho, Yael Kusne, et al.. (2024). PPM1D Somatic Mutations in Myeloid Neoplasms: Clinical Profile, Clonal Characteristics and Impact of Concurrent Somatic TP53 Mutations. Blood. 144(Supplement 1). 3218–3218. 1 indexed citations

Badar, Talha, James M. Foran, Mohamed A. Kharfan‐Dabaja, et al.. (2024). Venetoclax in Combination with Hypomethylating Agent (HMA) Compared to HMA Alone Improves Response but Not Survival in TP53-mutated High-Risk Myelodysplastic Syndrome: Real-World Mayo Clinic Series. Blood. 144(Supplement 1). 1823–1823. 1 indexed citations

Abdou, Yara, Paula R. Pohlmann, Richard T. Maziarz, et al.. (2024). A phase 1, first-in-human study of autologous monocytes engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants with HER2-overexpressing solid tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS2682–TPS2682. 4 indexed citations

Badar, Talha, Keith L. Knutson, James M. Foran, et al.. (2024). T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute myeloid leukemia. Blood Advances. 9(2). 239–243. 6 indexed citations

Mohty, Razan, Tea Reljic, Talha Badar, et al.. (2024). Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Promyelocytic Leukemia: Results of a Systematic Review and Meta-Analysis. Transplantation and Cellular Therapy. 30(6). 599.e1–599.e10. 1 indexed citations

Shahid, Zainab, Aaron Etra, John E. Levine, et al.. (2024). Defining and Grading Infections in Clinical Trials Involving Hematopoietic Cell Transplantation: A Report From the BMT CTN Infectious Disease Technical Committee. Transplantation and Cellular Therapy. 30(5). 540.e1–540.e13. 3 indexed citations

McCullough, Kristen, Aref Al‐Kali, Hassan B. Alkhateeb, et al.. (2023). Venetoclax + Cladribine + Low-Dose Cytarabine in Acute Myeloid Leukemia Relapsed or Refractory to Venetoclax + Hypomethylating Agent. Blood. 142(Supplement 1). 2853–2853. 1 indexed citations

Saifi, Omran, Scott C. Lester, William G. Breen, et al.. (2023). Incorporating radiation with anti‐CD19 chimeric antigen receptor T‐cell therapy for relapsed/refractory non‐Hodgkin lymphoma: A multicenter consensus approach. American Journal of Hematology. 99(1). 124–134. 9 indexed citations

10.

Barata, Anna, Hannah R. Abrams, Lih‐Wen Mau, et al.. (2023). What do patients think about palliative care? A national survey of hematopoietic stem cell transplant recipients. Blood Advances. 7(10). 2032–2041. 6 indexed citations

11.

Badar, Talha, James M. Foran, Aref Al‐Kali, et al.. (2023). U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood Cancer Journal. 13(1). 149–149. 7 indexed citations

12.

Baranwal, Anmol, Rong He, David S. Viswanatha, et al.. (2023). Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasms. Blood Advances. 8(3). 562–570. 1 indexed citations

13.

Baranwal, Anmol, Isla McKerrow Johnson, Mohamed A. Kharfan‐Dabaja, et al.. (2023). Comparison of Pretransplantation Prediction Models for Nonrelapse Mortality in Patients with Myelofibrosis Undergoing Allogeneic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(6). 360.e1–360.e8. 2 indexed citations

14.

Baranwal, Anmol, Khaled Ali, Mohamed A. Kharfan‐Dabaja, et al.. (2023). Surrogates of Endothelial Injury Predict Non-Relapse Mortality Among Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis. Transplantation and Cellular Therapy. 29(2). S9–S10. 1 indexed citations

15.

Iqbal, Madiha, Radhika Bansal, Allison Rosenthal, et al.. (2022). Impact of Rituximab and Corticosteroids on Late Cytopenias Post-Chimeric Antigen Receptor T Cell Therapy. Transplantation and Cellular Therapy. 28(10). 668.e1–668.e6. 5 indexed citations

16.

Rahman, Zaid Abdel, Ricardo Parrondo, Michael G. Heckman, et al.. (2021). Comparative study of therapy‐related and de novo adult b‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 196(4). 963–968. 7 indexed citations

17.

Iqbal, Madiha, Jonas Paludo, Allison Rosenthal, et al.. (2021). Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 22(2). e89–e95. 2 indexed citations

18.

Sharma, Akshay, Sherif M. Badawy, Elizabeth Suelzer, et al.. (2021). Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committee. Bone Marrow Transplantation. 56(4). 786–797. 4 indexed citations

19.

Murthy, Hemant S., et al.. (2019). Cytokine Release Syndrome: Current Perspectives. SHILAP Revista de lepidopterología. 1 indexed citations

20.

Lutfi, Forat, William Paul Skelton, Nosha Farhadfar, et al.. (2017). Poor Graft Function Following Autologous Stem Cell Transplant (ASCT): A Retrospective Analysis over Two Decades at a Transplant Center. Blood. 130. 4529–4529. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact